{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:33Z","timestamp":1790758593237,"version":"4.1.0"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aim was to investigate the prevalence of non-alcoholic steatohepatitis (NASH) and risk factors for hepatic fibrosis in morbidly obese patients submitted to bariatric surgery. This retrospective study recruited all patients submitted to bariatric surgery from January 2007 to December 2012 at a reference attendance center of Southern Brazil. Clinical and biochemical data were studied as a function of the histological findings of liver biopsies done during the surgery. Steatosis was present in 226 (90.4%) and NASH in 176 (70.4%) cases. The diagnosis of cirrhosis was established in four cases (1.6%) and fibrosis in 108 (43.2%). Risk factors associated with NASH at multivariate analysis were alanine aminotransferase (ALT) &gt;1.5 times the upper limit of normal (ULN); glucose \u2265 126 mg\/dL and triglycerides \u2265 150 mg\/dL. All patients with ALT \u22651.5 times the ULN had NASH. When the presence of fibrosis was analyzed, ALT &gt; 1.5 times the ULN and triglycerides \u2265 150 mg\/dL were risk factors, furthermore, there was an increase of 1% in the prevalence of fibrosis for each year of age increase. Not only steatosis, but NASH is a frequent finding in MO patients. In the present study, ALT \u2265 1.5 times the ULN identifies all patients with NASH, this finding needs to be further validated in other studies. Moreover, the presence of fibrosis was associated with ALT, triglycerides and age, identifying a subset of patients with more severe disease.<\/jats:p>","DOI":"10.3390\/ijms161025552","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T08:27:06Z","timestamp":1445675226000},"page":"25552-25559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients"],"prefix":"10.3390","volume":"16","author":[{"given":"Alexandre","family":"Losekann","sequence":"first","affiliation":[{"name":"Post-Graduation Program, Hepatology at Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre (UFCSPA), Porto Alegre 90.050-170, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Weston","sequence":"additional","affiliation":[{"name":"Centro de Tratamento da Obesidade (CTO), Hospital Santa Casa de Miseric\u00f3rdia de Porto Alegre, Porto Alegre 92.010-300, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Mattos","sequence":"additional","affiliation":[{"name":"Post-Graduation Program, Hepatology at Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre (UFCSPA), Porto Alegre 90.050-170, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Tovo","sequence":"additional","affiliation":[{"name":"Post-Graduation Program, Hepatology at Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre (UFCSPA), Porto Alegre 90.050-170, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"De Carli","sequence":"additional","affiliation":[{"name":"Centro de Tratamento da Obesidade (CTO), Hospital Santa Casa de Miseric\u00f3rdia de Porto Alegre, Porto Alegre 92.010-300, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Espindola","sequence":"additional","affiliation":[{"name":"Centro de Tratamento da Obesidade (CTO), Hospital Santa Casa de Miseric\u00f3rdia de Porto Alegre, Porto Alegre 92.010-300, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pioner","sequence":"additional","affiliation":[{"name":"Centro de Tratamento da Obesidade (CTO), Hospital Santa Casa de Miseric\u00f3rdia de Porto Alegre, Porto Alegre 92.010-300, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Coral","sequence":"additional","affiliation":[{"name":"Post-Graduation Program, Hepatology at Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre (UFCSPA), Porto Alegre 90.050-170, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2004-823098","article-title":"Nonalcoholic steatohepatitis","volume":"24","author":"Brunt","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Associations between nonalcoholic fatty liver disease and risk for hepatocellular cancer based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann. Med."},{"key":"ref_4","first-page":"5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1155\/2002\/534530","article-title":"Nonalcoholic steatohepatitis in nondiabetic obese patients","volume":"16","author":"Zamin","year":"2002","journal-title":"Can. J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1665-2681(19)31838-1","article-title":"Nonalcoholic fatty liver disease in severely obese individuals: The influence of bariatric surgery","volume":"7","author":"Cotrim","year":"2008","journal-title":"Ann. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","article-title":"Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease","volume":"137","author":"Mathurin","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s11695-011-0559-y","article-title":"Effect of bariatric surgery on liver fibrosis","volume":"22","author":"Moretto","year":"2012","journal-title":"Obes. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cgh.2011.07.007","article-title":"Increased perioperative mortality following bariatric surgery among patients with cirrhosis","volume":"9","author":"Mosko","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1381\/0960892053576820","article-title":"Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients","volume":"15","author":"Ong","year":"2005","journal-title":"Obes. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.21472","article-title":"Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery","volume":"14","author":"Gonzalez","year":"2008","journal-title":"Liver Transpl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.23521","article-title":"Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?","volume":"51","author":"Angulo","year":"2010","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.soard.2011.06.010","article-title":"Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery","volume":"8","author":"Chisholm","year":"2012","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s11695-015-1655-1","article-title":"Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese south indian patients undergoing bariatric surgery","volume":"25","author":"Praveenraj","year":"2015","journal-title":"Obes. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-277X.2005.00634.x","article-title":"Body mass index and waist circumference in non-alcoholic fatty liver disease","volume":"18","author":"Rocha","year":"2005","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00042737-200508000-00010","article-title":"Non-alcoholic fatty liver disease and insulin resistance: Importance of risk factors and histological spectrum","volume":"17","author":"Cotrim","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_23","first-page":"477","article-title":"APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH","volume":"101","author":"Kruger","year":"2011","journal-title":"South Afr. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Use of the FIB4 index for non-invasive evaluation of fibrosis in nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/10\/25552\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:50:48Z","timestamp":1760215848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/10\/25552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10]]}},"alternative-id":["ijms161025552"],"URL":"https:\/\/doi.org\/10.3390\/ijms161025552","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]}}}